Scholars and scientists in the history of the lymphatic system

par Natale, Gianfranco, Bocci, Guido, Ribatti, Domenico
Publié dans J Anat (2017)

The pharmacological bases of the antiangiogenic activity of paclitaxel

par Bocci, Guido, Di Paolo, Antonello, Danesi, Romano
Publié 2013

Metronomic chemotherapy for triple negative breast cancer?

par Di Desidero, Teresa, Kerbel, Robert S., Bocci, Guido
Publié dans Aging (Albany NY) (2016)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

par Di Desidero, Teresa, Orlandi, Paola, Gentile, Daniela, Bocci, Guido
Publié dans Front Oncol (2019)

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

par Bocci, Guido, Francia, Giulio, Man, Shan, Lawler, Jack, Kerbel, Robert S.
Publié 2003

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

par Di Desidero, Teresa, Xu, Ping, Man, Shan, Bocci, Guido, Kerbel, Robert S.
Publié dans Oncotarget (2015)

Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo

par Di Paolo, Antonello, Orlandi, Paola, Di Desidero, Teresa, Danesi, Romano, Bocci, Guido
Publié dans Oncol Res (2017)

Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

par Banchi, Marta, Orlandi, Paola, Gentile, Daniela, Alì, Greta, Fini, Elisabetta, Fontanini, Gabriella, Francia, Giulio, Bocci, Guido
Publié dans Am J Cancer Res (2020)

Definition of the microvascular pattern of the normal human adult mammary gland

par Naccarato, Antonio G, Viacava, Paolo, Bocci, Guido, Fanelli, Giovanni, Aretini, Paolo, Lonobile, Antonino, Montruccoli, Giancarlo, Bevilacqua, Generoso
Publié 2003

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

par Del Re, Marzia, Di Paolo, Antonello, van Schaik, Ron H., Bocci, Guido, Simi, Paolo, Falcone, Alfredo, Danesi, Romano
Publié 2010

Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation

par Manciu, Marian, Hosseini, Sorour, Di Desidero, Teresa, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A, Francia, Giulio
Publié dans Future Sci OA (2018)

Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction

par Bocci, Guido, Di Paolo, Antonello, Barbara, Cecilia, Masi, Gianluca, Fornaro, Lorenzo, Loupakis, Fotios, Allegrini, Giacomo, Falcone, Alfredo, Del Tacca, Mario, Danesi, Romano
Publié 2009

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

par Bocci, Guido, Fioravanti, Anna, Orlandi, Paola, Di Desidero, Teresa, Natale, Gianfranco, Fanelli, Giovanni, Viacava, Paolo, Naccarato, Antonio Giuseppe, Francia, Giulio, Danesi, Romano
Publié 2012

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

par Di Desidero, Teresa, Antonelli, Alessandro, Orlandi, Paola, Ferrari, Silvia Martina, Fioravanti, Anna, Alì, Greta, Fontanini, Gabriella, Basolo, Fulvio, Francia, Giulio, Bocci, Guido
Publié dans Cancer Lett (2017)

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

par Danesi, Romano, Innocenti, Federico, Fogli, Stefano, Gennari, Alessandra, Baldini, Editta, Di Paolo, Antonello, Salvadori, Barbara, Bocci, Guido, Conte, Pier Franco, Del Tacca, Mario
Publié 2002

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

par Canu, Bastianina, Fioravanti, Anna, Orlandi, Paola, Di Desidero, Teresa, Alì, Greta, Fontanini, Gabriella, Di Paolo, Antonello, Del Tacca, Mario, Danesi, Romano, Bocci, Guido
Publié 2011

Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients

par Valenzuela, Paloma, Oaxaca, Derrick, Desidero, Teresa Di, Parra, Karla, Rodriguez, Georgialina, Manciu, Marian, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A., Francia, Giulio
Publié dans Clin Exp Med (2020)

Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation

par Quattrini, Luca, Coviello, Vito, Sartini, Stefania, Di Desidero, Teresa, Orlandi, Paola, Ke, Yi-Yu, Liu, Kai-Lun, Hsieh, Hsing-Pang, Bocci, Guido, La Motta, Concettina
Publié dans Sci Rep (2019)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

par Lazzeri, Stefano, Orlandi, Paola, Figus, Michele, Fioravanti, Anna, Cascio, Elisa, Di Desidero, Teresa, Agosta, Elisa, Canu, Bastianina, Sartini, Maria Sole, Danesi, Romano, Nardi, Marco, Bocci, Guido
Publié 2012

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

par Cox, Maria Christina, Banchi, Marta, Pelliccia, Sabrina, Di Napoli, Arianna, Marcheselli, Luigi, Patti, Caterina, Anticoli Borza, Paola, Battistini, Roberta, Di Gregorio, Francesca, Orlandi, Paola, Bocci, Guido
Publié dans Cancer Chemother Pharmacol (2020)